Wakefield, MA · Founded 2011 · Privately Held (backing)
Developer of catheter-based neurolytic delivery systems designed for therapeutic intervention in hypertension. Ablative Solutions is based in Wakefield, MA and was founded in 2011. Its last reported valuation was $140 million in Jun 2022. It has raised $215 million across 4 recorded rounds; the latest was a $10.4 million early-stage round in Nov 2025.
Last reported valuation
$140.0M
Oct 2026
Priced at
—
Total raised
$214.6M
Last round
Early Stage VC
Nov 2025
Cap table — not yet on record
Ablative Solutions's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ablative Solutions with a free account
·The complete investor list: 11 names
·Watch Ablative Solutions: the Monday email on marks, rounds and moves
Where does Ablative Solutions's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Ablative Solutions's 4 recorded funding rounds.
